Clorox Financial Statements (CLX)
|
|
Report date
|
|
|
10.08.2022 |
30.06.2023 |
10.08.2023 |
30.06.2024 |
08.08.2024 |
|
30.10.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
7 107 |
7 389 |
7 389 |
7 093 |
7 093 |
|
7 382 |
Operating Income, bln rub |
|
|
489.0 |
1 224 |
1 224 |
923.0 |
916.0 |
|
1 165 |
EBITDA, bln rub |
? |
|
928.0 |
773.0 |
577.0 |
1 755 |
736.0 |
|
1 238 |
Net profit, bln rub |
? |
|
462.0 |
149.0 |
149.0 |
280.0 |
280.0 |
|
480.0 |
|
OCF, bln rub |
? |
|
786.0 |
|
1 158 |
0.000 |
695.0 |
|
743.0 |
CAPEX, bln rub |
? |
|
251.0 |
|
228.0 |
0.000 |
212.0 |
|
175.0 |
FCF, bln rub |
? |
|
535.0 |
|
930.0 |
0.000 |
483.0 |
|
568.0 |
Dividend payout, bln rub
|
|
|
571.0 |
|
583.0 |
0.000 |
595.0 |
|
448.0 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
123.6% |
0.00% |
391.3% |
0.00% |
212.5% |
|
93.3% |
|
OPEX, bln rub |
|
|
1 795 |
2 055 |
2 055 |
2 125 |
3 048 |
|
2 187 |
Cost of production, bln rub |
|
|
4 562 |
4 481 |
4 481 |
4 045 |
4 045 |
|
4 046 |
R&D, bln rub |
|
|
132.0 |
138.0 |
138.0 |
126.0 |
126.0 |
|
129.0 |
Interest expenses, bln rub |
|
|
106.0 |
90.0 |
90.0 |
90.0 |
90.0 |
|
85.0 |
|
Assets, bln rub |
|
|
6 158 |
5 945 |
5 945 |
5 751 |
5 751 |
|
5 497 |
Net Assets, bln rub |
? |
|
556.0 |
220.0 |
220.0 |
328.0 |
328.0 |
|
60.0 |
Debt, bln rub |
|
|
3 103 |
2 924 |
2 924 |
2 903 |
2 903 |
|
2 884 |
Cash, bln rub |
|
|
183.0 |
367.0 |
367.0 |
202.0 |
202.0 |
|
278.0 |
Net debt, bln rub |
|
|
2 920 |
2 557 |
2 557 |
2 701 |
2 701 |
|
2 606 |
|
Ordinary share price, rub |
|
|
141.0 |
159.0 |
159.0 |
136.5 |
136.5 |
|
123.3 |
Number of ordinary shares, mln |
|
|
123.1 |
123.6 |
123.6 |
124.2 |
124.2 |
|
123.8 |
|
Market cap, bln rub |
|
|
17 356 |
19 656 |
19 656 |
16 946 |
16 946 |
|
15 258 |
EV, bln rub |
? |
|
20 276 |
22 213 |
22 213 |
19 647 |
19 647 |
|
17 864 |
Book value, bln rub |
|
|
-1 886 |
-1 744 |
-1 744 |
-900 |
-1 581 |
|
-1 754 |
|
EPS, rub |
? |
|
3.75 |
1.21 |
1.21 |
2.25 |
2.25 |
|
3.88 |
FCF/share, rub |
|
|
4.35 |
0.00 |
7.52 |
0.00 |
3.89 |
|
4.59 |
BV/share, rub |
|
|
-15.3 |
-14.1 |
-14.1 |
-7.25 |
-12.7 |
|
-14.2 |
|
EBITDA margin, % |
? |
|
13.1% |
10.5% |
7.81% |
24.7% |
10.4% |
|
16.8% |
Net margin, % |
? |
|
6.50% |
2.02% |
2.02% |
3.95% |
3.95% |
|
6.50% |
FCF yield, % |
? |
|
3.08% |
0.00% |
4.73% |
0.00% |
2.85% |
|
3.72% |
ROE, % |
? |
|
83.1% |
67.7% |
67.7% |
85.4% |
85.4% |
|
800.0% |
ROA, % |
? |
|
7.50% |
2.51% |
2.51% |
4.87% |
4.87% |
|
8.73% |
|
P/E |
? |
|
37.6 |
131.9 |
131.9 |
60.5 |
60.5 |
|
31.8 |
P/FCF |
|
|
32.4 |
|
21.1 |
|
35.1 |
|
26.9 |
P/S |
? |
|
2.44 |
2.66 |
2.66 |
2.39 |
2.39 |
|
2.07 |
P/BV |
? |
|
-9.20 |
-11.3 |
-11.3 |
-18.8 |
-10.7 |
|
-8.70 |
EV/EBITDA |
? |
|
21.8 |
28.7 |
38.5 |
11.2 |
26.7 |
|
14.4 |
Debt/EBITDA |
|
|
3.15 |
3.31 |
4.43 |
1.54 |
3.67 |
|
2.11 |
|
R&D/CAPEX, % |
|
|
52.6% |
|
60.5% |
|
59.4% |
|
73.7% |
|
CAPEX/Revenue, % |
|
|
3.53% |
0.00% |
3.09% |
0.00% |
2.99% |
|
2.37% |
|
Clorox shareholders |